Drug Profile
Research programme: small molecule therapeutics - HitGen/The Scripps Research Institute/California Institute for Biomedical Research
Latest Information Update: 28 May 2021
Price :
$50
*
At a glance
- Originator California Institute for Biomedical Research; HitGen; The Scripps Research Institute
- Class Antineoplastics; Antivirals; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer; Viral infections
Most Recent Events
- 28 May 2021 No recent reports of development identified for research development in Cancer in China
- 28 May 2021 No recent reports of development identified for research development in Cancer in USA
- 28 May 2021 No recent reports of development identified for research development in Viral-infections in China